NCT02097953View on ClinicalTrials.gov

Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2016

Conditions
Drug InteractionsPharmacokinetics
Interventions
DRUG

Daptomycin

DRUG

Rifampin

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

lead

University of Utah

OTHER

NCT02097953 - Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin | Biotech Hunter | Biotech Hunter